MANILA, Philippines — The country’s pharmaceutical market is expected to reach P759 billion by 2030, supported by investments in local drug manufacturing, according to research and analysis firm BMI.

Sun Pharmaceutical Industries has announced the launch of its semaglutide injection in India under the brand names Noveltreat and Sematrinity, across multiple strengths for the treatment of obesity ...

Oil price spikes aren't the only impact of the ongoing Middle East conflict on the global economy. Here are three other major ...

Union Minister Jitendra Singh highlighted India's emerging role as a significant pharmaceutical economy. At a healthcare summit, he emphasized the country's shift from import-dependence to ...

Union Minister Jitendra Singh on Saturday said India is steadily evolving into a robust pharma economy, which will not only accelerate future growth but also emerge as a significant contributor to the ...

Dr Reddy's Laboratories has announced the launch of its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to GLP-1 receptor agonist-based therapy for the ...

A major employer in Swindon, Thermo Fisher, has pledged support for a campaign to promote growth and opportunity in the town.

Kansas House Speaker Dan Hawkins abruptly sent lawmakers home to block discussion on a drug pricing bill. What lawmakers are ...

With low dose starting at 1,290 per month, analysts are expecting a two-fold jump in the sale of GLP-1 units over the next three months due to the steep price cuts.